Target intelligence / Profile preview

Neocarzinostatin (NCS)

Target
NCS
Molecular classification
Enediyne antitumor antibiotic, Chromoprotein
01

Overview

Neocarzinostatin (NCS) is a macromolecular chromoprotein and an enediyne antitumor antibiotic secreted by Streptomyces macromomyceticus. It consists of a DNA-damaging chromophore and a protein that protects and delivers it to target DNA. NCS induces single- and double-strand breaks in DNA, leading to inhibition of DNA synthesis, cell cycle arrest, and apoptosis. It has been used clinically in Japan for liver cancer treatment, but its use elsewhere is limited to research due to stability issues. It serves as a radiomimetic agent and a tool for studying cellular responses to genotoxic stress.

Other names
ZinostatinumZINOSTATINVinostatin
02

Mechanism of action

Intercalates into DNA; generates benzenoid diradical via Bergman cyclization, leading to single- and double-strand DNA breaks and inhibition of DNA synthesis.

03

Biological functions

DNA damage inductionInhibition of DNA synthesisCell cycle arrestApoptosis inductionCytotoxicity
04

Disease associations

Cancer
05

Safety considerations

CytotoxicityGenotoxicityPotential health hazards upon exposure

Beyond the preview

Go deeper on Neocarzinostatin (NCS).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neocarzinostatin (NCS).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call